New Medication In Research Trials
http://www.medilexicon.com/medicalnews.php?newsid=223004
In preclinical studies, DB959 appears to have a favorable effect on blood lipids as well as blood sugar; it raises HDL while lowering both triglycerides and blood glucose. These results were accomplished without causing the weight gain that is seen with other PPAR agonists.
Maybe one day there will be a three in one pill or injection we can take/have once a month to ameliorate DM T1, hypertension AND cholesterol...? 8)
http://www.medilexicon.com/medicalnews.php?newsid=223004
In preclinical studies, DB959 appears to have a favorable effect on blood lipids as well as blood sugar; it raises HDL while lowering both triglycerides and blood glucose. These results were accomplished without causing the weight gain that is seen with other PPAR agonists.
Maybe one day there will be a three in one pill or injection we can take/have once a month to ameliorate DM T1, hypertension AND cholesterol...? 8)
